Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

NCT07485114 · clinicaltrials.gov ↗

RECRUITING

Status

300

Enrollment

OTHER_GOV

Sponsor class

Conditions

Renal Cell Carcinoma (Kidney Cancer)
Non Small Cell Lung Cancer
Hepatocellular Carcinoma
Transitional Cell Carcinoma

Interventions

DIAGNOSTIC_TEST: Serum Gal-3 level, blood count and chemistry included liver function

Sponsor

Daniel Keizman